- Home
- / Bone Biologics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Bone Biologics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.4
2024-10-29
Market Capitalization
$3.6 M
2024-10-29
Revenue
$1.1 B
FY, 2020
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1B | 1.1B | |||||||||||||
| General and administrative expense | 120.0 | 1.5M | 8.3M | 6.2M | 3.8M | 2.7M | 1.4M | 484.3K | 1.0M | 2.1M | 2.5M | 2.1M | 2.2M | ||
| Operating expense total | 120.0 | 2.1M | 12.0M | 17.8M | 5.0M | 2.8M | 2.4M | 825.0K | 3.7M | 9.4M | 4.2M | 3.2M | |||
| EBIT | (3.0M) | (12.0M) | (17.8M) | (2.6M) | (2.8M) | (2.4M) | (825.0K) | (1.1M) | (3.7M) | (9.4M) | (4.2M) | (3.2M) | |||
| EBIT margin, % | -0.2% | -0.1% | |||||||||||||
| Interest income | 55.7K | 122.0K | |||||||||||||
| Interest expense | 1.9K | ||||||||||||||
| Pre tax profit | (4.5K) | (5.2K) | (4.8K) | (4.4M) | (13.9M) | (21.0M) | (7.0M) | (4.4M) | (3.4M) | (1.8M) | (1.6M) | ||||
| Income tax expense | 400.0 | 400.0 | 400.0 | 1.6K | 8.8K | 2.2K | 1.6K | 1.7K | 1.6K | 1.6K | 1.6K | ||||
| Net Income | (4.9K) | (5.6K) | (5.2K) | (4.4M) | (13.9M) | (21.0M) | (7.1M) | (4.4M) | (3.4M) | (1.8M) | (1.6M) | (1.5M) | (8.9M) | (4.1M) | (3.1M) |
| EPS | (34.0) | (4.8) | (2.6) |